RD-O24

N/A

Report date: 2022/07/01 15:29:28

Base Information

Drug NameRD-O24
Drug Alias NameRD-O24
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionAnti-Hepatocyte growth factor receptor
TargetsHepatocyte growth factor receptor
Therapy Area/IndicationsMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Turin
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Turin
Inactive CompaniesN/A
Active IndicationsMultiple Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A